Clearmind Medicine (CMND) Competitors $0.98 +0.01 (+0.82%) Closing price 04:00 PM EasternExtended Trading$0.95 -0.03 (-2.65%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. LPCN, QTTB, CARM, CASI, GELS, HOTH, LEXX, BIVI, SONN, and ALLRShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Lipocine (LPCN), Q32 Bio (QTTB), Carisma Therapeutics (CARM), CASI Pharmaceuticals (CASI), Gelteq (GELS), Hoth Therapeutics (HOTH), Lexaria Bioscience (LEXX), BioVie (BIVI), Sonnet BioTherapeutics (SONN), and Allarity Therapeutics (ALLR). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors Lipocine Q32 Bio Carisma Therapeutics CASI Pharmaceuticals Gelteq Hoth Therapeutics Lexaria Bioscience BioVie Sonnet BioTherapeutics Allarity Therapeutics Lipocine (NASDAQ:LPCN) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability. Do institutionals and insiders believe in LPCN or CMND? 9.1% of Lipocine shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 6.4% of Lipocine shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts rate LPCN or CMND? Lipocine presently has a consensus target price of $9.00, indicating a potential upside of 183.91%. Given Lipocine's stronger consensus rating and higher possible upside, equities analysts clearly believe Lipocine is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lipocine 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, LPCN or CMND? Lipocine has higher revenue and earnings than Clearmind Medicine. Lipocine is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLipocine$11.20M1.51$10K-$1.02-3.11Clearmind MedicineN/AN/A-$5.26M-$1.10-0.89 Does the media favor LPCN or CMND? In the previous week, Clearmind Medicine had 2 more articles in the media than Lipocine. MarketBeat recorded 3 mentions for Clearmind Medicine and 1 mentions for Lipocine. Lipocine's average media sentiment score of 1.87 beat Clearmind Medicine's score of 0.74 indicating that Lipocine is being referred to more favorably in the media. Company Overall Sentiment Lipocine Very Positive Clearmind Medicine Positive Is LPCN or CMND more profitable? Lipocine's return on equity of -26.68% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets LipocineN/A -26.68% -24.77% Clearmind Medicine N/A -164.79%-71.12% Which has more risk and volatility, LPCN or CMND? Lipocine has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. SummaryLipocine beats Clearmind Medicine on 11 of the 14 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.15M$2.42B$5.52B$9.32BDividend YieldN/A1.79%4.25%4.05%P/E Ratio-0.899.1828.1519.68Price / SalesN/A736.93437.63100.28Price / CashN/A160.6835.5357.53Price / Book1.344.698.235.67Net Income-$5.26M$30.99M$3.23B$257.51M7 Day Performance1.03%0.60%-0.01%0.52%1 Month Performance12.64%7.93%5.61%8.84%1 Year Performance-46.45%-5.48%26.52%14.18% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.9155 of 5 stars$0.98+0.8%N/A-56.2%$4.15MN/A-0.89N/ALPCNLipocine3.0148 of 5 stars$3.14+1.0%$9.00+186.6%-58.0%$16.64M$11.20M-3.0810QTTBQ32 Bio2.6739 of 5 stars$1.39+2.2%$12.17+775.3%-91.9%$16.59M$1.16M-0.2839CARMCarisma Therapeutics3.01 of 5 stars$0.40+1.8%$1.93+378.9%-67.5%$16.51M$19.63M-0.2620CASICASI Pharmaceuticals4.2401 of 5 stars$1.41+5.7%$4.00+184.7%-79.2%$16.34M$28.54M-0.55180Gap DownGELSGelteqN/A$1.90+13.8%N/AN/A$15.76M$100K0.00N/AGap DownHOTHHoth Therapeutics3.263 of 5 stars$1.30+10.2%$4.00+207.7%+52.3%$15.59MN/A-1.144Positive NewsLEXXLexaria Bioscience1.9448 of 5 stars$0.88+0.6%$5.00+468.2%-72.0%$15.36M$460K-1.497BIVIBioVie1.0677 of 5 stars$8.47+4.6%N/A+60.3%$15.04MN/A-0.1110Positive NewsGap UpSONNSonnet BioTherapeutics3.7584 of 5 stars$4.47-5.5%$20.00+347.4%+38.4%$14.97M$20K0.0010News CoverageGap DownHigh Trading VolumeALLRAllarity Therapeutics0.4525 of 5 stars$1.03+4.7%N/A-83.1%$14.83MN/A0.0010News Coverage Related Companies and Tools Related Companies LPCN Competitors QTTB Competitors CARM Competitors CASI Competitors GELS Competitors HOTH Competitors LEXX Competitors BIVI Competitors SONN Competitors ALLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
